Kaitlyn Arsenault
Chief Financial Officer · Skye Bioscience, Inc.
- 2024
- Feb 10, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kaitlyn Arsenault files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Partners VII, LLC - $445K in SKYE purchases and sales in the last 12 months
- Andrew J. Schwab - $445K in SKYE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kaitlyn Arsenault?
Kaitlyn Arsenault is a corporate insider, tracked as Chief Financial Officer of Skye Bioscience, Inc. (SKYE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kaitlyn Arsenault last file a Form 4?
The most recent primary Form 4 on record is dated 10 February 2026, one of 3 filings going back to 2024.
Has Kaitlyn Arsenault been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($217K) across all tracked filings.
